Debbie L Hay Selected Research

Adrenomedullin

10/2022	A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond.
1/2022	Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
1/2021	Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study.
2/2011	Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
10/2009	Calcitonin gene-related peptide, adrenomedullin and flushing.
12/2006	Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
4/2003	Desensitisation of adrenomedullin and CGRP receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debbie L Hay Research Topics

Disease

40	Migraine Disorders (Migraine) 03/2024 - 01/2005
7	Pain (Aches) 04/2024 - 01/2016
7	Obesity 01/2023 - 09/2010
7	Headache (Headaches) 11/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 10/2011
2	Weight Loss (Weight Reduction) 01/2023 - 07/2015
2	Facial Pain (Myofacial Pain) 01/2022 - 06/2015
2	Migraine without Aura (Common Migraine) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 07/2015 - 11/2014
2	Insulin Resistance 09/2010 - 01/2008
1	Anorexia 02/2024
1	Hypersensitivity (Allergy) 01/2021
1	Photophobia (Light Sensitivity) 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2020
1	Chronic Disease (Chronic Diseases) 01/2018
1	Headache Disorders (Headache Syndromes) 05/2017
1	Diabetes Mellitus 06/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Decompression Sickness (Bends) 12/2013
1	Neurogenic Inflammation 12/2013
1	Osteoporosis 09/2012
1	Neoplasms (Cancer) 02/2011
1	Body Weight (Weight, Body) 09/2010
1	Septic Shock (Toxic Shock Syndrome) 12/2009
1	Flushing 10/2009
1	Sepsis (Septicemia) 04/2003

Drug/Important Bio-Agent (IBA)

26	Calcitonin Gene-Related PeptideIBA 03/2024 - 12/2006
18	Peptides (Polypeptides)IBA 04/2024 - 04/2003
13	Islet Amyloid PolypeptideIBA 03/2024 - 11/2014
10	NeuropeptidesIBA 01/2022 - 09/2010
9	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 10/2022 - 02/2011
7	AdrenomedullinIBA 10/2022 - 04/2003
7	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 12/2006
5	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2022 - 01/2016
4	Hormones (Hormone)IBA 01/2023 - 11/2014
4	pramlintide (Symlin)FDA Link 01/2021 - 11/2014
4	olcegepantIBA 01/2018 - 01/2005
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2024 - 10/2011
3	Calcitonin Receptors (Calcitonin Receptor)IBA 03/2024 - 04/2017
2	LigandsIBA 03/2024 - 12/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 09/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2010
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 11/2022 - 02/2022
2	Monoclonal AntibodiesIBA 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Islet Amyloid Polypeptide ReceptorsIBA 01/2021 - 04/2017
2	Amylin Receptor AgonistsIBA 09/2018 - 07/2015
2	telcagepantIBA 01/2018 - 12/2009
2	Insulin (Novolin)FDA Link 06/2016 - 11/2014
2	Amino Acids FDA Link 01/2016 - 12/2013
2	Secretin FDA Link 09/2012 - 10/2011
2	LipidsIBA 09/2010 - 01/2008
1	gastric inhibitory polypeptide receptorIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	tirzepatideIBA 01/2023
1	IncretinsIBA 01/2023
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 02/2022
1	atogepantIBA 01/2022
1	AntibodiesIBA 12/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2020
1	rimegepant sulfateIBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 09/2018
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2018
1	calcitonin gene-related peptide (8-37)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 06/2016
1	Calcitonin Receptor-Like ProteinIBA 01/2012

Therapy/Procedure

14	Therapeutics 01/2023 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2023
1	Precision Medicine 01/2021